ProPharma Group Executive and Leadership Team

July, 2026

Leadership Overview

ProPharma Group has 7 executives leading key functions including information technology, finance, human resources, pharmacovigilance, life science consulting, clinical research, and general management.

Driven by a commitment to excellence, ProPharma Group provides comprehensive regulatory and compliance solutions tailored for the dynamic medical industry, fostering innovation and ensuring patient safety through expert guidance.

Leadership Roles at ProPharma Group

  • Chief Financial Officer - Jon Otterberg
  • President, Pharmacovigilance - Laura Hopper
  • President Life Science Consulting - James Kolbet
  • President, Clinical Research Solutions - Daniel Ryan
  • President - Jason DeGoes
  • Chief Information Officer - Kirk Wroblewski
  • Chief Human Resources Officer - Rachel Bias
  • Jon Otterberg - Chief Financial Officer

    Jon Otterberg, the Chief Financial Officer at ProPharma Group, manages the organization's financial health and strategic fiscal planning. Directing all financial operations, Otterberg ensures robust accounting practices and drives profitability through meticulous budget management and resource allocation. This executive position involves developing financial models that support ProPharma Group's growth initiatives and market expansion within the medical sector. By guiding investment strategies and optimizing financial performance, Jon Otterberg directly contributes to the company's long-term stability and operational success. The Chief Financial Officer's oversight extends to financial reporting, risk management, and ensuring compliance with all relevant financial regulations.

    Laura Hopper - President, Pharmacovigilance

    Laura Hopper, the President, Pharmacovigilance at ProPharma Group, directs the comprehensive pharmacovigilance services offered to the pharmaceutical and biotech industries. Leading a dedicated team, Hopper ensures the meticulous monitoring, detection, and assessment of adverse events, safeguarding public health and regulatory compliance. This executive leadership position involves developing and implementing robust safety surveillance systems tailored to client needs. By driving innovation in safety data management and reporting, Laura Hopper enhances ProPharma Group's reputation as a trusted partner in drug safety. The President, Pharmacovigilance's expertise is crucial for navigating complex global regulatory landscapes and ensuring client success.

    James Kolbet - President Life Science Consulting

    James Kolbet, the President Life Science Consulting at ProPharma Group, spearheads the strategic direction and delivery of consulting services for life science organizations. Guiding expert teams, Kolbet focuses on enhancing client capabilities in areas such as regulatory affairs, market access, and product development. This leadership role is pivotal in translating complex scientific and regulatory challenges into actionable business strategies for clients in the pharmaceutical, biotechnology, and medical device sectors. By fostering client relationships and driving service innovation, James Kolbet strengthens ProPharma Group's position as a premier consulting partner. The President Life Science Consulting's vision ensures clients achieve their commercial and regulatory objectives efficiently.
    James Kolbet

    Daniel Ryan - President, Clinical Research Solutions

    Daniel Ryan, the President, Clinical Research Solutions at ProPharma Group, oversees the comprehensive suite of services supporting clinical trials and research. Leading teams of clinical operations experts, Ryan ensures the efficient execution of studies, adherence to regulatory standards, and timely data collection for clients in the medical and pharmaceutical industries. This executive position involves developing strategies to optimize trial performance, manage complex project timelines, and navigate global regulatory requirements. By driving operational excellence and fostering strong client partnerships, Daniel Ryan enhances ProPharma Group's capacity to accelerate drug development and bring life-saving therapies to market. The President, Clinical Research Solutions' focus is on delivering high-quality, data-driven results.
    Daniel Ryan

    Jason DeGoes - President

    Jason DeGoes, the President at ProPharma Group, drives the overall strategic vision and operational execution for the organization. Leading across multiple business units, DeGoes ensures seamless integration of services and alignment with the company's mission to provide expert regulatory and compliance solutions for the medical industry. This executive leadership role involves fostering a culture of innovation, client-centricity, and continuous improvement. By guiding strategic growth initiatives and overseeing key business development efforts, Jason DeGoes strengthens ProPharma Group's market presence and impact. The President's commitment is to advancing the company's capabilities and delivering exceptional value to clients worldwide.

    Kirk Wroblewski - Chief Information Officer

    Kirk Wroblewski, the Chief Information Officer at ProPharma Group, directs the company's technology strategy and infrastructure. Overseeing all IT operations, Wroblewski ensures the secure and efficient management of data critical to regulatory and compliance solutions. This leadership role involves architecting scalable systems that support ProPharma Group's expanding service offerings in the medical industry. By optimizing digital platforms, Kirk Wroblewski drives operational efficiency and enhances the delivery of services to clients. The Chief Information Officer's focus remains on leveraging technology to maintain a competitive edge and uphold the highest standards of data integrity and client confidentiality across all business functions.

    Rachel Bias - Chief Human Resources Officer

    Rachel Bias, the Chief Human Resources Officer at ProPharma Group, leads all human capital strategies and organizational development initiatives. Overseeing talent acquisition, employee relations, and compensation programs, Bias cultivates a high-performance culture essential for delivering specialized regulatory and compliance solutions. This critical role involves aligning HR policies with ProPharma Group's mission to support the medical industry. By fostering employee engagement and professional growth, Rachel Bias ensures the organization retains top talent and maintains operational excellence. The Chief Human Resources Officer's strategic focus includes developing leadership pipelines and championing diversity and inclusion across the workforce.
    Rachel Bias

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding ProPharma Group Top Executives and Leadership Team

    Who leads ProPharma Group?
    ProPharma Group is led by Jon Otterberg (Chief Financial Officer), along with executives such as Laura Hopper (President, Pharmacovigilance) and James Kolbet (President Life Science Consulting).
    Who is part of ProPharma Group’s executive team?
    The executive team of ProPharma Group includes leaders such as Jon Otterberg (Chief Financial Officer), Laura Hopper (President, Pharmacovigilance), James Kolbet (President Life Science Consulting) and other senior executives.
    How many executives does ProPharma Group have?
    ProPharma Group has 7 executives leading key business areas.
    What roles are included in ProPharma Group’s leadership team?
    The leadership team of ProPharma Group includes roles such as Chief Financial Officer, President, Pharmacovigilance, President Life Science Consulting, President, Clinical Research Solutions, President.